EA199800176A1 - Применение производных сульфаминовой кислоты , ацилсульфонамидов или сульфонилкарбаматов для получения лекарственных средств, снижающих уровень липопротеинов - Google Patents
Применение производных сульфаминовой кислоты , ацилсульфонамидов или сульфонилкарбаматов для получения лекарственных средств, снижающих уровень липопротеиновInfo
- Publication number
- EA199800176A1 EA199800176A1 EA199800176A EA199800176A EA199800176A1 EA 199800176 A1 EA199800176 A1 EA 199800176A1 EA 199800176 A EA199800176 A EA 199800176A EA 199800176 A EA199800176 A EA 199800176A EA 199800176 A1 EA199800176 A1 EA 199800176A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- group
- medicament
- manufacture
- acid derivatives
- sulfamic acid
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- -1 sulfamic acid derivatives acyl sulfonamides Chemical class 0.000 title 2
- 102000004895 Lipoproteins Human genes 0.000 title 1
- 108090001030 Lipoproteins Proteins 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 229940124530 sulfonamide Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000001624 naphthyl group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 208000018262 Peripheral vascular disease Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 208000037803 restenosis Diseases 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Настоящее изобретение относится к новой области применения в качестве лекарственных средств соединений формулы Iгде Х и Y означают атомы кислорода, серы и группу (CR'R"), в которой n означает число от 1 до 4, R означает атом водорода, алкильную или бензильную группу, Rи Rозначают фенильную или замещенную фенильную группу, нафтильную или замещенную нафтильную группу, арилалкильную группу, алкильную цепь, адамантильную или циклоалкильную группу. Их применяют для терапии таких заболеваний сосудов мозга, как удар, заболевания периферических сосудов и рестеноз.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US303195P | 1995-08-04 | 1995-08-04 | |
PCT/US1996/011366 WO1997005868A1 (en) | 1995-08-04 | 1996-07-08 | Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels |
Publications (2)
Publication Number | Publication Date |
---|---|
EA199800176A1 true EA199800176A1 (ru) | 1998-10-29 |
EA002435B1 EA002435B1 (ru) | 2002-04-25 |
Family
ID=21703764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA199800176A EA002435B1 (ru) | 1995-08-04 | 1996-07-08 | Способ снижения уровня липопротеина (а) в сыворотке или в плазме крови млекопитающих |
Country Status (27)
Country | Link |
---|---|
US (1) | US6117909A (ru) |
EP (1) | EP0841913B1 (ru) |
JP (1) | JPH11510184A (ru) |
KR (1) | KR19990036127A (ru) |
CN (1) | CN1192140A (ru) |
AT (1) | ATE232097T1 (ru) |
AU (1) | AU716255B2 (ru) |
BG (1) | BG63863B1 (ru) |
CA (1) | CA2221729A1 (ru) |
CZ (1) | CZ26198A3 (ru) |
DE (1) | DE69626118T2 (ru) |
DK (1) | DK0841913T3 (ru) |
EA (1) | EA002435B1 (ru) |
EE (1) | EE9800037A (ru) |
ES (1) | ES2191762T3 (ru) |
GE (1) | GEP20012511B (ru) |
HR (1) | HRP960341A2 (ru) |
HU (1) | HUP9900668A3 (ru) |
IL (1) | IL122247A0 (ru) |
NO (1) | NO980466L (ru) |
NZ (1) | NZ312571A (ru) |
PL (1) | PL185943B1 (ru) |
PT (1) | PT841913E (ru) |
SK (1) | SK12598A3 (ru) |
UA (1) | UA46030C2 (ru) |
WO (1) | WO1997005868A1 (ru) |
ZA (1) | ZA966617B (ru) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1584333A3 (en) * | 1998-01-28 | 2009-04-29 | Warner-Lambert Company LLC | Use of acetylcoenzime A inhibitors for treating Alzheimer's disease |
OA11584A (en) * | 1998-07-21 | 2004-07-20 | Warner Lambert Co | Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions. |
IT1303249B1 (it) * | 1998-10-23 | 2000-11-06 | Dompe Spa | Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono. |
JP2003513909A (ja) * | 1999-11-05 | 2003-04-15 | ワーナー−ランバート・カンパニー | Acat阻害剤によるプラーク破裂の予防 |
CA2369967A1 (en) * | 2001-02-12 | 2002-08-12 | Joseph Anthony Cornicelli | Methods of treating nuclear factor-kappa b mediated diseases and disorders |
AR037097A1 (es) | 2001-10-05 | 2004-10-20 | Novartis Ag | Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento |
US6939224B2 (en) * | 2002-03-12 | 2005-09-06 | Igt | Gaming device having varying risk player selections |
TWI815829B (zh) | 2017-11-14 | 2023-09-21 | 美商默沙東有限責任公司 | 作為吲哚胺2,3-二氧酶(ido)抑制劑之新穎經取代二芳基化合物 |
US11498904B2 (en) | 2017-11-14 | 2022-11-15 | Merck Sharp & Dohme Llc | Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5003106A (en) * | 1983-07-19 | 1991-03-26 | American Cyanamid Company | Antiatherosclerotic ureas and thioureas |
KR100193743B1 (ko) * | 1990-10-30 | 1999-06-15 | 로즈 암스트롱, 크리스틴 에이. 트러트웨인 | 옥시술포닐 카르바메이트 |
US5245068A (en) * | 1990-10-30 | 1993-09-14 | Warner-Lambert Company | Oxysulfonyl carbamates |
IL101785A0 (en) * | 1991-05-10 | 1992-12-30 | Fujisawa Pharmaceutical Co | Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
IL109431A (en) * | 1993-05-14 | 2001-01-11 | Warner Lambert Co | Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds |
US5491172A (en) * | 1993-05-14 | 1996-02-13 | Warner-Lambert Company | N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
-
1996
- 1996-07-08 SK SK125-98A patent/SK12598A3/sk unknown
- 1996-07-08 AT AT96923687T patent/ATE232097T1/de not_active IP Right Cessation
- 1996-07-08 AU AU64541/96A patent/AU716255B2/en not_active Ceased
- 1996-07-08 CN CN96196033A patent/CN1192140A/zh active Pending
- 1996-07-08 EE EE9800037A patent/EE9800037A/xx unknown
- 1996-07-08 HU HU9900668A patent/HUP9900668A3/hu unknown
- 1996-07-08 KR KR1019980700795A patent/KR19990036127A/ko not_active Application Discontinuation
- 1996-07-08 NZ NZ312571A patent/NZ312571A/en unknown
- 1996-07-08 ES ES96923687T patent/ES2191762T3/es not_active Expired - Lifetime
- 1996-07-08 GE GEAP19964165A patent/GEP20012511B/en unknown
- 1996-07-08 JP JP9508427A patent/JPH11510184A/ja active Pending
- 1996-07-08 DE DE69626118T patent/DE69626118T2/de not_active Expired - Fee Related
- 1996-07-08 CZ CZ98261A patent/CZ26198A3/cs unknown
- 1996-07-08 WO PCT/US1996/011366 patent/WO1997005868A1/en not_active Application Discontinuation
- 1996-07-08 CA CA002221729A patent/CA2221729A1/en not_active Abandoned
- 1996-07-08 EP EP96923687A patent/EP0841913B1/en not_active Expired - Lifetime
- 1996-07-08 PL PL96324908A patent/PL185943B1/pl unknown
- 1996-07-08 EA EA199800176A patent/EA002435B1/ru not_active IP Right Cessation
- 1996-07-08 DK DK96923687T patent/DK0841913T3/da active
- 1996-07-08 IL IL12224796A patent/IL122247A0/xx unknown
- 1996-07-08 PT PT96923687T patent/PT841913E/pt unknown
- 1996-07-08 US US09/000,296 patent/US6117909A/en not_active Expired - Fee Related
- 1996-07-16 HR HR60/003,031A patent/HRP960341A2/hr not_active Application Discontinuation
- 1996-08-02 ZA ZA9606617A patent/ZA966617B/xx unknown
- 1996-08-07 UA UA97126430A patent/UA46030C2/uk unknown
-
1998
- 1998-01-30 BG BG102222A patent/BG63863B1/bg unknown
- 1998-02-03 NO NO980466A patent/NO980466L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPH11510184A (ja) | 1999-09-07 |
KR19990036127A (ko) | 1999-05-25 |
HUP9900668A3 (en) | 2000-08-28 |
CZ26198A3 (cs) | 1998-07-15 |
CA2221729A1 (en) | 1997-02-20 |
BG63863B1 (bg) | 2003-04-30 |
EP0841913A1 (en) | 1998-05-20 |
IL122247A0 (en) | 1998-04-05 |
EP0841913B1 (en) | 2003-02-05 |
NO980466D0 (no) | 1998-02-03 |
AU716255B2 (en) | 2000-02-24 |
ATE232097T1 (de) | 2003-02-15 |
US6117909A (en) | 2000-09-12 |
GEP20012511B (en) | 2001-08-27 |
HRP960341A2 (en) | 1998-02-28 |
ES2191762T3 (es) | 2003-09-16 |
PL324908A1 (en) | 1998-06-22 |
PL185943B1 (pl) | 2003-09-30 |
HUP9900668A2 (hu) | 1999-06-28 |
BG102222A (en) | 1998-09-30 |
PT841913E (pt) | 2003-06-30 |
WO1997005868A1 (en) | 1997-02-20 |
SK12598A3 (en) | 1999-02-11 |
DK0841913T3 (da) | 2003-05-05 |
ZA966617B (en) | 1997-02-18 |
EA002435B1 (ru) | 2002-04-25 |
EE9800037A (et) | 1998-08-17 |
DE69626118D1 (de) | 2003-03-13 |
NO980466L (no) | 1998-02-03 |
UA46030C2 (uk) | 2002-05-15 |
DE69626118T2 (de) | 2003-11-27 |
AU6454196A (en) | 1997-03-05 |
NZ312571A (en) | 2000-07-28 |
CN1192140A (zh) | 1998-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2133163T3 (es) | Esteres (o tioesteres) del acido n-acilsulfamico y esteres (o tioesteres) del acido n-sulfonilcarbamico como agentes hipercolesterolemicos. | |
NO843836L (no) | Terapeutisk aktive sulfamatderivater | |
EA199800043A1 (ru) | Замещенные (сульфиновой кислоты, сульфоновой кислоты, сульфониламино или сульфиниламино) n-[(аминоиминометил)фенилалкил]азагетероциклил-амидные производные | |
ATE157870T1 (de) | Ophthalmische zusammensetzung enthaltend ein 1,5- benzoxathiepin-derivat zur behandlung von glaukoma | |
FR2809396B1 (fr) | Nouvelles molecules possedant une activite calcimimetique et leur mode de preparation | |
FR2800735B1 (fr) | Nouvelles aralkyle-1,2-diamines possedant une activite calcimimetique et leur mode de preparation | |
PA8477001A1 (es) | Inhibidores no peptidilicos de la union a las celulas dependientes de la vla-4 utiles en el tratamiento de enfermedades inflamatorias autoinmunes y respiratorias | |
NO942372L (no) | Propensyrederivater | |
EA199800176A1 (ru) | Применение производных сульфаминовой кислоты , ацилсульфонамидов или сульфонилкарбаматов для получения лекарственных средств, снижающих уровень липопротеинов | |
DE58904143D1 (de) | Arylalkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel. | |
DE3888340D1 (de) | Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit. | |
ATE99934T1 (de) | Heteroaryl-3-oxo-propannitril-derivate, nuetzlich zur behandlung von rheumatoider arthritis und anderen autoimmunkrankheiten. | |
DE69518706T2 (de) | Verwendung von Diphenylethanderivaten zur Herstellung eines Arzneimittels zur Behandlung von Glaukom | |
ES2158290T3 (es) | Derivados de tiazolidinona opticamente activos. | |
DE69421457D1 (de) | Verwendung von N-(Pyridinyl)-1H-Indol-1-Aminen zur Herstellung eines Medikamentes zur Behandlung von zwangsneurotischen Erkrankungen | |
MX9709275A (es) | Uso de los derivados del acido sulfamico, carbamatos acil sulfonamidas o sulfonil para la manufactura de un medicamento para disminuir los niveles de lipoproteinas. | |
ATE191458T1 (de) | Benzol-derivate | |
DE69619088D1 (de) | Quinoxalin-Derivate zur Behandlung von Tinnitus | |
SE9401965D0 (sv) | New compounds | |
KR950017956A (ko) | N-치환 아자비시클로헵탄 유도체, 그의 제조 방법 및 용도 | |
TH25930A (th) | กรรมวิธีการเตรียม ซับสทิทิวเทด เบนซีนซัลโฟนิล-ยูเรีย-ไธโอยูเรีย การใช้สารดังกล่าวเป็นยาหรือใช้รักษาโรค และยาซึ่งมีสารดังกล่าว | |
TH7867EX (th) | อนุพันธ์ 1, 5 -เบนโซไธอาเซพีน , การเตรียมสารและการใช้สารในการรักษาความผิดปกติเกี่ยวกับหัวใจ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |